Advertisement

Topics

Gemphire reports positive top-line results from Phase IIb trial of HoFH drug

19:00 EDT 28 Jun 2017 | Net Resources International

US-based Gemphire Therapeutics has reported positive top-line results from a Phase IIb clinical trial (COBALT-1) of gemcabene to treat patients with homozygous familial hypercholesterolemia (HoFH).

Original Article: Gemphire reports positive top-line results from Phase IIb trial of HoFH drug

NEXT ARTICLE

More From BioPortfolio on "Gemphire reports positive top-line results from Phase IIb trial of HoFH drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...